Apeaz
Natural health product licensed in Canada
- Other names
- Flexilon
- Licence holder
- Innovus Pharmaceuticals, Inc.
- NPN or DIN-HM
- 80082618
- Status
- Inactive licence
- Licence date
- 24 January 2018
- Revision date
- 17 August 2022
- Form
- Crème
- Route of administration
- Topique
- Application type
- Officinale
Oral dose analysis does not apply without an established exclusively oral route.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source |
|---|---|
| l-Menthol Source : l-Menthol | 7.5 Pour cent |
| d-camphre Source : d-Camphre | 4 Pour cent |
| 2-méthoxycarbonyl)phénol Source : Salicylate de méthyle | 10 Pour cent |
Non-medicinal ingredients
(p)-hydroxybenzoate de propyle, Monostéarate de glycéryle, Eau purifiée, Bleu FD&C n° 1, Alcool cétéarylique, Carbomère 940, PEG-100, Méthylsulfonylméthane, Poly(sorbate) 60, Triéthanolamine, (p)-hydroxybenzoate de méthyle, Jaune FD&C No. 5, Huile minérale, Sulfate de glucosamine, Alcool stéarylique
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 1 Crème | minimum: 3 Tous les jours ; maximum: 4 Tous les jours |
Uses authorised in Canada
Temporarily relieves aches and pains of muscles and joints associated with one or more of the following: Simple backache, lumbago, strains and sprains (involving muscles, tendons, and/or ligaments), and arthritis.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
Hypersensitivity, rashes and/or burning discomfort have been known to occur; in which case, discontinue use. If you experience pain, swelling or blistering, stop use and get medical help right away.
- Précautions et mises en garde
Keep out of the reach of children. If overdose or accidental ingestion occurs, call a Poison Control Center immediately. If symptoms worsen, or re-occur within a few days, discontinue use and consult a health care practitioner. If you are pregnant or breastfeeding, consult a healthcare practitioner prior to use.
Source
Official Health Canada record, licence 80082618
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2022. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.